Astute Medical is committed to improving patient outcomes through the identification and validation of novel biomarkers. Its immunoassay development and measurement methods help assess high-risk acute medical conditions and diseases. Innovative biomarkers. Smarter healthcare.
Avidity Biosciences is a privately held biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC™) – which combine the strengths of monoclonal antibodies and siRNA-based therapeutics to overcome barriers to the delivery of siRNA and target genetic drivers of disease.
Avidity Biosciences has raised $29 million in venture financing from a top-tier group of investors.
Savara Pharmaceuticals is a U.S.-based emerging pharmaceutical development company with an affiliate site in Denmark. The company is focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions.